Orthopedic surgery or orthopedics (also spelled orthopaedics) is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and non-surgical means to treat musculoskeletal trauma, sports injuries, degenerative diseases, infections, tumors, and congenital conditions.
The Canadian Institutes of Health Research (CIHR) and the Canadian Medical Association Journal (CMAJ) today honoured eight outstanding Canadian individuals and teams with the first ever CIHR-CMAJ Top Canadian Achievements in Health Research Awards, which recognize and celebrate Canadian health research and innovation excellence.
The Orthopaedic Trauma Institute (OTI) at the San Francisco General Hospital and Trauma Center and University of California, San Francisco has been chosen to serve as one of 12 core clinical centers in a newly established Extremity Trauma Clinical Research Consortium.
According to George Kappler, "If hospitals were subjected to the same protection standards as factories, many would have been shut down a long time ago." Those are tough words for healthcare workers to hear as they brace for an onslaught of H1N1 patients, but the CEO of Kappler, Inc., a 33-year veteran in the protective garment business, knows of what he speaks.
Recent advances in diagnostic imaging techniques and hip arthroscopy procedures are giving physicians and surgeons better tools with which to treat hip pain. The 2009 International Society for Hip Arthroscopy meeting, hosted by Hospital for Special Surgery in New York, brings together leading surgeons from all over the world to take an in-depth look at hip arthroscopy and its potential benefits.
MedShape Solutions, Inc. announced today the first FDA cleared shape memory PEEK (polyaryletheretherketone) device for orthopedics using proprietary shape memory PEEK Altera(TM) material. The Morphix(TM) Suture Anchor was recently granted FDA clearance and will be released to select U.S. markets in the coming months. Over $2.5B of PEEK-based implants are sold every year in the field of orthopedics.
The U.S. Food and Drug Administration (FDA) yesterday released preliminary results of a review of its internal procedures surrounding the review of ReGen Biologics’Menaflex collagen meniscus implant for use in the U.S.
Versa Card, Inc., doing business as "Spine Pain Management, Inc." (the "Company"), is pleased to announce that the first spine treatment center has opened in Houston, Texas.
West Georgia Health System and Perot Systems today announced that Perot Systems will provide Revenue Cycle services to the LaGrange, Georgia-based hospital organization. The agreement will enable WGHS to utilize Perot Systems' revenue cycle technology and its proven best practices for revenue cycle improvements.
Today RetireSafe, representing 400,000 senior supporters across America, called on the U.S. Senate, starting with the Senate Finance Committee, to stop the proposed rationing of high-quality hospital care to Medicare patients.
SAGE is partnering with the International Cartilage Repair Society (ICRS) to launch Cartilage in 2010. A peer-reviewed quarterly journal, Cartilage will be a forum for the exchange of ideas for the many types of researchers and clinicians involved in cartilage biology and repair.
The Kosciusko County Community Foundation (KCCF) and BioCrossroads announced that a $7 million grant, made by Lilly Endowment Inc. to KCCF, will support the establishment of OrthoWorx, a Warsaw-based, industry, community and education initiative to advance and support growth and innovation within the region's uniquely concentrated, globally significant orthopedics device sector.
A recent United States Army study found that excessive bone growth, also known as heterotopic ossificiation (HO), affects up to 70 percent of soldiers who are severely wounded during combat. A much smaller percentage of the civilian population also suffers from HO following trauma or invasive surgery. The excessive bone forms within muscles and other tissues causing severe pain, reduced mobility and even local paralysis if untreated.
Under a voluntary resolution agreement reached with the U.S. Department of Health and Human Services (HHS), deaf or hard-of-hearing patients at the Mid-Maryland Musculoskeletal Institute (MMI) of Frederick, Md., will be screened and provided with sign language interpreters whenever interpreter services are necessary for effective communication. MMI is an 11-physician orthopedic practice with offices in Frederick and Hagerstown, Md., serving approximately 1,000 patients per month.
New stem cell studies at the University of Maryland Dental School demonstrate that surgeons could one day routinely use strong, moldable, and injectable pastes to regenerate needed bone tissue to repair broken bones, fractures, genetic defects, even combat bone wounds.
Aspyra, Inc. (AMEX:APY) announced today that the Company has contracted with Renaissance Radiology Medical Group, Inc., a leading provider of outpatient diagnostic services throughout southern California, to provide Aspyra’s integrated AccessRAD RIS/PACS solution.
Cancer patients residing in and near Michigan are one step closer to receiving one of the most advanced forms of treatment available with a new partnership being formed between McLaren Health Care and ProTom International, a Texas-based health care technology company.
ReGen Biologics (OTC: RGBO) (“ReGen” or “the company”) is pleased to report that Steven Tradonsky, MD of San Diego Sports Medicine recently treated a young veteran with the Menaflex collagen meniscus implant at the VA Medical Center in La Jolla, California.
Orthopaedic Associates of Michigan is one of 12 clinical centers selected to participate in a newly established Extremity Trauma Clinical Research Consortium, funded by the Department of Defense and coordinated by the Research Center at the Johns Hopkins Bloomberg School of Public Health.
Six Wisconsin biotechnology companies have been selected the winners of the first Emerging Company Showcase. The showcase is part of the Biotechnology Vision Summit 2009, being held on Wednesday, Oct. 7, at the Madison Marriott West in Madison, Wis. The summit and the showcase are being hosted by BioForward, the member-driven state association that is the voice of Wisconsin’s biotechnology industry.
Medtronic, Inc. (NYSE:MDT), today announced the full U.S. launch of the KYPHON Cement Delivery System (CDS), adding an innovative bone cement delivery option to its extensive KYPHON Balloon Kyphoplasty product portfolio for the treatment of vertebral compression fractures (VCFs).
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.